Intellectual Property

  • December 08, 2025

    Apple Gets Fed. Circ. To OK Axed Mobile Wallet Patent

    The Federal Circuit on Monday issued a one-word order affirming a Patent Trial and Appeal Board decision invalidating claims in a virtual wallet patent challenged by Apple and owned by Mozido, the predecessor of Fintiv Inc.

  • December 08, 2025

    X Claims Engineer Stole 6M Lines Of Code To Launch New Co.

    X Corp. is accusing a fired software engineer of stealing trade secrets to start her own company, alleging in a federal lawsuit that she exploited upheaval following Elon Musk's April 2022 purchase of the Twitter social media platform to download 6 million lines of proprietary source code. 

  • December 08, 2025

    2nd Circ. Doubts Ex-Basketball Players' NIL Claims Are Timely

    A Second Circuit panel on Monday persistently pushed the attorney for former college basketball players to explain why the players waited so long to claim the unpaid use of their images by the NCAA, years after their careers had ended.

  • December 08, 2025

    Fed. Circ. Won't Revive Express Mobile's Patents Or $40M Win

    The Patent Trial and Appeal Board rightfully invalidated claims of three Express Mobile web-design patents, and a Delaware federal judge properly found Shopify didn't infringe additional, related patents, the Federal Circuit held Monday.

  • December 08, 2025

    Amazon, UL Say Chinese Cos. Lied About E-Bike Safety Tests

    Amazon and product safety organization UL are accusing a number of Chinese firms of falsely promoting their electric scooters and e-bikes as certified by UL despite never actually having their products tested by the 131-year-old safety group.

  • December 08, 2025

    What To Do When Jurors Don't 'Trust The Science'

    The pandemic and initiatives from the second administration of President Donald Trump challenging decades of established scientific norms have made science more politicized, and attorneys say picking a jury and presenting scientific evidence is increasingly challenging.

  • December 08, 2025

    Ex-Archetype Capital Exec Hit With Trade Secret Injunction

    A Nevada federal court on Friday temporarily blocked the former executive of a litigation finance business from using its trade secrets, finding the evidence indicates that his new law firm employer leveraged its proprietary mass tort review system. 

  • December 08, 2025

    Ex-Josh Cellars President Fights Gibson Dunn Withdrawal Bid

    The former president of the company behind the Josh Cellars wine brand disputed Gibson Dunn & Crutcher LLP's version of events around his allegedly unpaid legal bills, saying he has questions about the reasonableness of the firm's charges, which must be arbitrated per his contract with the firm.

  • December 08, 2025

    Carlton Fields Steps Aside In 'Irreconcilable' Miss America Case

    A Florida federal judge allowed Carlton Fields and its attorneys on Monday to withdraw from representing the plaintiffs in a dispute over the ownership of the Miss America pageant, after the firm said "irreconcilable differences" drew it to ask to step down.

  • December 08, 2025

    Del. Chancellor Finds Prince Estate Battle Will Play On

    Delaware's chancellor on Monday tossed some but not all amended counterclaims in a long-running battle among some relatives of the musician known as Prince and managing members of his estate, while saying a neutral party could help resolve the case.

  • December 08, 2025

    Fed. Circ. Backs Erasure Of $64M IP Verdict Against Goodyear

    The Federal Circuit on Monday affirmed an Ohio federal judge's decision to erase a $64 million jury verdict against Goodyear, agreeing that a Czech self-inflating tire company's suit had alleged misappropriation of trade secrets that were insufficiently defined, not secret or not used by Goodyear.

  • December 08, 2025

    Jury Expert Sues Atty For 'Pirating' Her Jan. 6 Venue Report

    A New Hampshire defense attorney representing a defendant charged for crimes related to the storming of the U.S. Capitol on Jan. 6, 2021, has been sued in D.C. federal court for allegedly stealing a copyrighted study analyzing attitudes in the jury pool of the District of Columbia.

  • December 08, 2025

    Justices Turn Down Machine Learning Patent Eligibility Case

    The U.S. Supreme Court on Monday left intact a decision that Recentive Analytics Inc. machine learning patents are invalid for claiming only abstract ideas, turning aside the company's argument in a dispute with Fox Corp. that the ruling effectively bars many artificial intelligence patents.

  • December 08, 2025

    Justices Skip 'WallStreetBets' TM Ownership Case

    The U.S. Supreme Court on Monday declined to hear an appeal from the creator of Reddit's WallStreetBets, who sought review of a Ninth Circuit decision that the social media company owned the trademark rights to the popular investing forum's name.

  • December 05, 2025

    Fed. Circ. Questions Whether Ingevity Can Duck $85M Verdict

    The Federal Circuit spent Friday morning debating whether Ingevity Corp.'s argument that it should be immune from an $85 million antitrust verdict holds water because the chemical and carbon product maker thought it was enforcing its patent rights, even though the jury said it was illegal tying.

  • December 05, 2025

    Calif. Agency Hires Ex-DOJ Crypto Enforcement Director

    The California Department of Financial Protection and Innovation has brought on a new general counsel who previously served in leadership positions with the U.S. Department of Justice, including director of its cryptocurrency enforcement team.

  • December 05, 2025

    SG Urges Justices To Hear Hikma's 'Skinny Label' Patent Case

    The U.S. solicitor general on Friday urged the U.S. Supreme Court to hear Hikma Pharmaceuticals Inc.'s appeal of a decision reviving a patent suit involving its "skinny label" on a generic heart drug, saying the ruling puts the availability of lower-cost generics at risk.

  • December 05, 2025

    Judge Won't Lift Stay On Hopewell Drug Launch

    A Delaware federal judge has shot down Hopewell Pharma Ventures' bid to lift a regulatory stay on approval of its planned generic version of German drugmaker Merck's blockbuster multiple sclerosis drug Mavenclad.

  • December 05, 2025

    ITC Bans Infringing Drill Bit Imports After Fed. Circ. Remand

    The U.S. International Trade Commission has held that a group of foreign companies is violating Section 337 of the Tariff Act by shipping diamond drill bit components that infringe a U.S. company's patent and issued an order banning such imports after the case was remanded by the Federal Circuit.

  • December 05, 2025

    Taylor Swift Wants Poet's 'Frivolous' $25M Suit Tossed

    Taylor Swift on Friday asked a Florida federal court to dismiss a $25 million copyright infringement lawsuit against her, calling it a "frivolous and harassing lawsuit" claiming copyright infringement of concepts and words that cannot be owned by one person.

  • December 05, 2025

    Columbia, Seirus Settle Long-Running Design Patent Suit

    Columbia Sportswear has agreed to a settlement to bring an end to its long-running infringement suit against rival Seirus Innovative Accessories Inc. over a clothing design patent, after a U.S. Patent and Trademark Office examiner upheld the patent last month.

  • December 05, 2025

    Skybound Hit With $4M IP Theft Suit Over 'Stray' Videogame

    Skybound Game Studios stole video game designer iam8bit's trade secrets and confidential information to negotiate a deal behind its back to launch "Stray" for the Nintendo Switch with a publisher while cutting iam8bit out of the profits, according to a $4 million fraud suit filed in California state court.

  • December 05, 2025

    Conde Nast Says 'Dogue' Dog Magazine Rips Off 'Vogue' TM

    Conde Nast sued a dog-centered fashion magazine Dogue in California federal court Friday for trademark infringement, arguing that the defendant purposely chose its style to resemble the famous Vogue logo to confuse consumers into thinking the defendant is associated with Conde Nast.  

  • December 05, 2025

    Fed. Circ. Revives Targeted Ad Patent Suit Against Meta

    The Federal Circuit revived an online advertising company's suit accusing Meta Platforms Inc. of infringing its patent covering a targeted advertising technology, finding Friday that a lower court "implicitly construed" an important claim term without letting the plaintiff challenge the construction.

  • December 05, 2025

    Pharma Co. Says Ex-Staff Used Secrets To Compete

    Pharmaceutical supplier New Life Medicals (USA) Inc. told a North Carolina state court that a former warehouse manager, a freelance contractor and a business partner conspired to steal confidential information to form a competing venture only 10 miles away.

Expert Analysis

  • Eye Drop Ruling Clarifies Importance Of Patent Phrasing

    Author Photo

    The Federal Circuit's recent ruling in Eye Therapies v. Slayback, rejecting the Patent Trial and Appeal Board's interpretation of "consisting essentially of," highlights the importance of using clear and consistent terms throughout a patent's filing history to shield it against future challenges, says Liliana Di Nola-Baron at Panitch Schwarze.

  • How Courts Are Addressing The Use Of AI In Discovery

    Author Photo

    In recent months, several courts have issued opinions on handling discovery issues involving artificial intelligence, which collectively offer useful insights on integrating AI into discovery and protecting work product in connection with AI prompts and outputs, says Philip Favro at Favro Law.

  • AI Infrastructure Growth Brings Unique IP Considerations

    Author Photo

    The explosive rise of artificial intelligence has triggered an equally dramatic transformation in the supporting infrastructure required to meet growing AI demand, and the technology used in these data centers has its own intellectual property considerations to navigate, says Vincent Allen at Carstens Allen.

  • Series

    Adapting To Private Practice: From ATF Director To BigLaw

    Author Photo

    As a two-time boomerang partner, returning to BigLaw after stints as a U.S. attorney and the director of the Bureau of Alcohol, Tobacco, Firearms and Explosives, people ask me how I know when to move on, but there’s no single answer — just clearly set your priorities, says Steven Dettelbach at BakerHostetler.

  • IPR Decisions Clarify Stewart's 'Settled Expectations' Factor

    Author Photo

    Recent discretionary denial decisions from U.S. Patent and Trademark Office acting Director Coke Morgan Stewart have begun to illuminate the contours of her "settled expectations" doctrine, informing when it might be worth petitioning for inter partes review if the patent at issue has been in force for a few years, say attorneys at Morgan Lewis.

  • How To Increase 3rd-Party Preissuance Patent Submissions

    Author Photo

    Attorneys Marian Underweiser and Marc Ehrlich, who helped draft the America Invents Act, discuss changes that the U.S. Patent and Trademark Office could potentially implement to facilitate its hopes for increased participation in front-end patent challenges.

  • Anthropic Ruling Creates Fair Use Framework For AI Training

    Author Photo

    A California federal court’s recent ruling that Anthropic’s use of copyrighted books to train its large language model qualified as fair use provides important guidance for both artificial intelligence developers and copyright holders because it distinguishes between transformative uses and unauthorized uses involving pirated or format-shifted works, say attorneys at Ropes & Gray.

  • Series

    Playing Baseball Makes Me A Better Lawyer

    Author Photo

    Playing baseball in college, and now Wiffle ball in a local league, has taught me that teamwork, mental endurance and emotional intelligence are not only important to success in the sport, but also to success as a trial attorney, says Kevan Dorsey at Swift Currie.

  • Assessing Impact Of USPTO's New Patent Policies

    Author Photo

    Recent data shows how the U.S. Patent and Trademark Office's new patent policies are affecting America Invents Act trial institution rates, including spurring an uptick in discretionary denials, say attorneys at Armond Wilson.

  • Series

    Law School's Missed Lessons: Skillful Persuasion

    Author Photo

    In many ways, law school teaches us how to argue, but when the ultimate goal is to get your client what they want, being persuasive through preparation and humility is the more likely key to success, says Michael Friedland at Friedland Cianfrani.

  • Fed. Circ. Ingenico Ruling Pivotal For IPR Estoppel Landscape

    Author Photo

    The Federal Circuit's recent decision in Ingenico v. Ioengine brings long-awaited clarity to the scope of inter partes review estoppel, confirming that a patent challenger is not precluded from relying on the same or substantially similar prior art in both IPR and district court proceedings, so long as it is used to support a different invalidity theory, say attorneys at Irwin IP.

  • Litigation Inspiration: How To Respond After A Loss

    Author Photo

    Every litigator loses a case now and then, and the sting of that loss can become a medicine that strengthens or a poison that corrodes, depending on how the attorney responds, says Bennett Rawicki at Hilgers Graben.

  • How Patent Attys Can Carefully Integrate LLMs Into Workflows

    Author Photo

    With artificial intelligence-powered tools now being developed specifically for the intellectual property domain, patent practitioners should monitor evolving considerations to ensure that their capabilities are enhanced — rather than diminished — by these resources, say attorneys at McDonnell Boehnen.

  • The Metamorphosis Of The Major Questions Doctrine

    Author Photo

    The so-called major questions doctrine arose as a counterweight to Chevron deference over the past few decades, but invocations of the doctrine have persisted in the year since Chevron was overturned, suggesting it still has a role to play in reining in agency overreach, say attorneys at Crowell & Moring.

  • New PTAB Denial Processes Grow More And More Confusing

    Author Photo

    Guidance from the U.S. Patent and Trademark Office about the Patent Trial and Appeal Board's new workload management and discretionary denial processes has been murky and inconsistent, and has been further muddled by the acting director's seemingly contradictory decisions, say attorneys at Finnegan.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.